TTNP TITAN PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2024 - Compliance with Nasdaq listing requirements Titan Pharmaceuticals has regained compliance with the minimum bid price requirement and satisfies all criteria for continued listing on The Nasdaq Capital Market.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC